BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med 2021;10:5698. [PMID: 34884399 DOI: 10.3390/jcm10235698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Candelli M. Microbiota: Not Just a Gut Feeling. JCM 2022;11:6180. [DOI: 10.3390/jcm11206180] [Reference Citation Analysis]
2 Varesi A, Campagnoli LIM, Fahmideh F, Pierella E, Romeo M, Ricevuti G, Nicoletta M, Chirumbolo S, Pascale A. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment. Int J Mol Sci 2022;23:12289. [PMID: 36293176 DOI: 10.3390/ijms232012289] [Reference Citation Analysis]
3 Ilieva NM, Wallen ZD, De Miranda BR. Oral ingestion of the environmental toxicant trichlorethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease. Toxicol Appl Pharmacol 2022;:116176. [PMID: 35914559 DOI: 10.1016/j.taap.2022.116176] [Reference Citation Analysis]
4 Ilieva NM, Wallen ZD, De Miranda BR. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s disease.. [DOI: 10.1101/2022.02.19.481161] [Reference Citation Analysis]
5 Srivastava A, Kataria A, Yadav DK, Han I, Choi E. Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease. Human-Gut Microbiome 2022. [DOI: 10.1016/b978-0-323-91313-3.00003-9] [Reference Citation Analysis]